最新更新 :
19/11/2024
抗癌藥物   Vincristine sulfate  
注射液
溶液稳定性 混合物稳定性 影响稳定性的因素 兼容性 用药途径 引用文献 PDF
   化学式  

商品名   商品名     

商品名仅供参考, 药品所用的辅料可能依国家或厂商不同有所不同。

Cellecristin 德国
Citomid 哥伦比亚, 墨西哥, 智利, 秘鲁
Crisovin 厄瓜多尔, 哥伦比亚, 墨西哥
Cytocristin 马来西亚
DBL vincristine sulfate 新西蘭, 马来西亚
Farmistin 德国
Marqibo 美国
Nefixol 墨西哥
Oncocristin 哥伦比亚
Oncovin 丹麦, 卢森堡, 哥伦比亚, 墨西哥, 奥地利, 摩洛哥, 沙特阿拉伯, 法国, 瑞典, 瑞士, 芬兰, 英国, 阿联酋
Onkocristin 德国
Sindovin 伊朗
Sulfato de vincristine 委内瑞拉
Unicristin 秘鲁
Vinblax 墨西哥
Vincasar 墨西哥, 美国
Vincrisin 比利时
Vincristin 匈牙利, 奥地利, 德国, 瑞士
Vincristina 伊朗, 冰岛, 厄瓜多尔, 哥伦比亚, 委内瑞拉, 意大利, 智利, 秘鲁, 西班牙, 阿根廷
Vincristine 卢森堡, 土耳其, 希腊, 挪威, 摩洛哥, 法国, 瑞典, 瑞士, 突尼斯, 马来西亚
Vincristine sulfat 土耳其
Vincristine sulfate 加拿大, 美国
Vincristine sulphate 埃及, 新西蘭, 波兰, 爱尔兰, 英国, 阿联酋, 马来西亚
Vincristinesulfaat 荷兰
Vincristinum 卢森堡
Vincrisul 西班牙
Vinlon Lyo 秘鲁
Vinracine 埃及, 马来西亚
Vintec 墨西哥
引用文献   注射液   引用文献 : Vincristine sulfate  
种类 出版物
3 文献 Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
26 文献 Stewart JT, Warren FW, King DT, Venkateshwaran TG, Ponder GW, Fox JL.
Stability of ondansetron hydrochloride, doxorubicin hydrochloride, and dacarbazine or vincristine sulfate in elastomeric portable infusion devices and polyvinyl chloride bags.
Am J Health-Syst Pharm 1997 ; 54: 915-920.
32 文献 Nyhammar EK, Johansson SG, Seiving BE.
Stability of doxorubicin and vincristine sulfate in two portable infusion-pump reservoirs.
Am J Health-Syst Pharm 1996 ; 53: 1171-1173.
57 文献 Mayron D, Gennaro AR.
Stability and compatibility of granisetron hydrochloride in IV solutions and oral liquids and during simulated Y-site injection with selected drugs.
Am J Health-Syst Pharm 1996 ; 53: 294-304.
81 文献 Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678.
84 文献 Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
99 文献 Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
144 文献 Dine T, Luyckx M, Cazin JC, Goudaliez F, Mallevais ML.
Stability and compatibility studies of vinblastine, vincristine, vindesine and vinorelbine with PVC infusion bags.
Int J Pharm 1991 ; 77: 279-285.
150 文献 Aujoulat P, Coze C, Braguer D, Raybaud C.
Physicochemical compatibility of methotrexate with co-administered drugs during cancer chemotherapy regimens.
J Pharm Clin 1993 ; 12: 31-35.
167 文献 Francomb MM, Ford JL, Lee MG.
Adsorption of vincristine, vinblastine, doxorubicin and mitoxantrone to in-line intravenous filters.
Int J Pharm 1994 ; 103: 87-92.
169 文献 Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
244 文献 Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
248 文献 Trissel LA, Martinez JF.
Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection.
Am J Hosp Pharm 1993 ; 50: 300-304.
249 文献 Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
251 文献 Trissel LA, Gilbert DL, Martinez JF.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
307 文献 Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
334 文献 Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
335 文献 Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406.
408 文献 Beijnen JH, Neef C, Meuwissen OJAT, Rutten JJMH, Rosing H, Underberg WJM.
Stability of intravenous admixtures of doxorubicin and vincristine.
Am J Hosp Pharm 1986 ; 43: 3022-3027.
431 文献 McRae MP, King JC.
Compatibility of antineoplastic, antibiotic and corticosteroid drugs in intravenous admixtures.
Am J Hosp Pharm 1975 ; 33: 1010-1013.
481 文献 Beijnen JH, Vendrig DEMM, Underberg WJM.
Stability of vinca alkaloid anticancer drugs in three commonly used infusion fluids.
J Parenter Sci Technol 1989 ; 43: 84-87.
491 文献 Turowski RC, Durthaler JM.
Visual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2181-2184.
492 文献 Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189.
703 文献 Butler LD, Munson JM, DeLuca PP.
Effect of inline filtration on the potency of low-dose drugs.
Am J Hosp Pharm 1980 ; 37: 935-941.
763 文献 Cohen MH, Jonhson-Early A, Hood MA, McKenzie M, Citron ML, Jaffe N, Krasnow SH.
Drug precipitation within IV tubing : A potential hazard of chemotherapy administration.
Cancer Treat Rep 1985 ; 69: 1325-1326.
857 文献 Kanke M, Eubanks JL, DeLuca PP.
Binding of selected drugs to a “treated” inline filter.
Am J Hosp Pharm 1983 ; 40: 1323-1328.
905 文献 Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
921 文献 Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
1026 文献 Mayron D, Gennaro AR.
Stability and compatibility of topotecan hydrochloride with selected drugs.
Am J Health-Syst Pharm 1999 ; 56: 875-881.
1033 文献 Wolfe JL, Thoma LA, Du C, Goldspiel BR, Gallelli JF, Grimes GJ, Potti GK.
Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection.
Am J Health-Syst Pharm 1999 ; 56: 985-989.
1408 文献 Priston MJ, Sewell GJ.
Stability of three cytotoxic drugs infusions in the Graseby 9000 ambulatory infusion pump.
J Oncol Pharm Practice 1998 ; 4: 143-149.
1410 文献 Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1423 文献 Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1496 文献 Trissel LA, Martinez JF, Gilbert DL.
Screening cladribine for Y-site physical compatibility with selected drugs.
Hosp Pharm 1996 ; 31: 1425-1428.
1520 实验室 Etude de stabilité des médicaments en Ecoflac®
B Braun 2001
1602 文献 Trissel LA, Zhang Y, Cohen MR.
The stablity of diluted vincristine sulfate used as a deterrent to inadvertent intrathecal injection.
Hosp Pharm 2001 ; 36: 740-745.
1606 文献 Yuan P, Grimes GJ, Shankman SE, Daniels CE, Goldspiel BR, Potti GK.
Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
Am J Health-Syst Pharm 2001 ; 58: 594-598.
1625 文献 Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1662 文献 Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
J Oncol Pharm Practice 2002 ; 8: 33-37.
1925 文献 Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
1953 文献 Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982 文献 Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2094 文献 Trittler R.
Stability of intravenous admixtures of doxorubicin and vincristine confirmed by LC-MS.
EJHP Science 2006 ; 12, 1: 10-12.
2247 文献 Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
3119 海报 Henriet Th, El Kateb N, Jourdan N, Faure P, Bellenger P.
Stabilité de la vincristine sans conservateurs.
Congrès HOPIPHARM 2010
3214 文献 Trittler R, Sewell G.
Stability of vincristine (TEVA) in original vials after re-use in dilute infusions in polyolefin bags and in polypropylene syringes.
EJOP 2011 ; 5,1: 10-14.
3578 实验室 Cisplatin - Summary of Product Characteristics
Accord Healthcare 2011
3644 实验室 Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
4102 文献 Svirskis D, Behera S, Naidoo N, Beachman J, Raina T, Zhou Y, Berkahn L, Costello I, Gu Y.
Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastromeric pump supporting transition of the EPOCH regimen to oupatient care.
J Oncol Pharm Practice 2018 ;25,4:831-840.

  Mentions Légales